Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 1% higher and the iShares Biotechnology ETF (IBB) down 0.5%
Novartis (NVS) shares were up more than 6% after the company said phase 3 trials of remibrutinib showed significantly reduced annualized relapse rates compared with teriflunomide in adults with relapsing multiple sclerosis.
Medtronic (MDT) stock was up more than 2% after the company posted higher fiscal Q1 adjusted earnings and revenue.
MiniMed (MMED) reported a fiscal Q1 breakeven, compared with a loss a year earlier, as net sales increased during the period. MiniMed shares were down more than 5% premarket.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.